Structural proteins in cosmetic applications

A film-forming, water-soluble structural protein addresses ethical and environmental concerns in cosmetics by forming a protective layer on skin and hair, enhancing texture and performance, while avoiding the limitations of natural alternatives.

WO2026233561A1PCT designated stage Publication Date: 2026-11-12INSEMPRA GMBH +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/EP2025/062722
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Filing Date
2025-05-09
Publication Date
2026-11-12

AI Technical Summary

Technical Problem

Natural structural proteins used in cosmetics face ethical concerns, environmental impacts, and solubility issues, leading to high costs and potential allergic reactions, while film builders often have build-up effects due to low water solubility.

Method used

A film-forming, water-soluble structural protein is developed using Al-based computational tools and microbial manufacturing, providing a sustainable alternative that forms a thin, continuous layer on skin, hair, or mucosa, enhancing product performance and texture.

Benefits of technology

The new protein offers ethical and environmental benefits, improves skin and hair texture, and allows for the creation of protective barriers without the drawbacks of traditional animal-derived proteins.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure IMGF000022_0001
    Figure IMGF000022_0001
  • Figure IMGF000022_0002
    Figure IMGF000022_0002
  • Figure IMGF000008_0001_TABLE
    Figure IMGF000008_0001_TABLE
Patent Text Reader

Abstract

The present invention relates to a cosmetic composition comprising a film-forming, water-soluble structural protein and its use in cosmetic applications.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] Insempra GmbH

[0002] Our Ref.: 1293-2 PCT

[0003] STRUCTURAL PROTEINS IN COSMETIC APPLICATIONS

[0004] The present invention relates to a cosmetic composition comprising a film-forming, water-soluble structural protein and its use in cosmetic applications.

[0005] BACKGROUND OF THE INVENTION

[0006] The cosmetics industry is increasingly shifting towards sustainability, driven by consumer demand for eco-friendly and ethical products. This trend includes the use of natural and biodegradable ingredients, reducing plastic packaging, and adopting cruelty-free and vegan formulations. Brands are also investing in sustainable sourcing, minimizing water usage, and incorporating upcycled or lab-grown ingredients to reduce environmental impact. Advances in biotechnology enable the creation of plant-based and synthetic alternatives to traditional animal-derived compounds, making cosmetics more sustainable without compromising effectiveness. Overall, the industry is embracing greener practices to promote both environmental responsibility and high-quality beauty products.

[0007] Structural proteins play a crucial role in cosmetic formulations due to their ability to enhance skin elasticity, hydration, and hair strength. In modern cosmetics, structural proteins are often derived from natural sources such as animal tissues, fish, or plants.

[0008] Typical examples of structural proteins are collagen, elastin, silk, and keratin. Collagen is widely used in anti-aging products to improve skin firmness and reduce wrinkles. Elastin contributes to skin resilience and flexibility, making it a common ingredient in skin care formulations. Silk is a natural protein-based material which allows many cosmetic applications, including hair care. Keratin is primarily found in hair care products, helping to repair damage, strengthen hair fibers, and improve overall texture.

[0009] However, structural proteins derived from natural resources, such as collagen, elastin, silk, and keratin, have several disadvantages in cosmetics. Many structural proteins come from animal by-products (e.g., bovine or marine collagen, wool-derived keratin), raising ethical concerns for vegan and cruelty-free consumers. Harvesting these proteins from natural sources can have environmental impacts, including overfishing (for marine collagen) or excessive livestock farming, which contributes to deforestation and greenhouse gas emissions. Natural proteins may cause allergic reactions or sensitivities in some individuals, making them unsuitable for certainconsumers. In addition, extracting and purifying structural proteins from natural sources can be expensive, increasing product costs for manufacturers and consumers.

[0010] Another disadvantage of structural proteins with high molecular weights is often the missing water solubility. Therefore, such proteins must be hydrolyzed (like animal-derived silk) or additional process steps are necessary to transfer the protein powder into at least water dispersible formulations (like hydrogels).

[0011] Film builders are also of big interest in the cosmetic market, because they can be beneficial to protect and repair hair and skin. However, they often have a build-up effect (like silicones), e.g. because of their low water solubility.

[0012] Thus, there is a need for bioengineered protein alternatives that offer similar benefits with fewer drawbacks to make cosmetics more sustainable and accessible.

[0013] The present inventors provide herewith a cosmetic composition comprising a new filmforming, water-soluble structural protein. This protein was designed by combining Al-based computational tools, proprietary high throughput material property screening methods and microbial manufacturing. With a fermentation approach, the artificial, computer generated, and non-animal derived protein was produced on a large scale and tested for cosmetic applications.

[0014] The present inventors could show that the new water-soluble structural protein forms a thin, continuous layer or film on the skin, hair, nails, or mucosa when applied. It is used to create a protective barrier, enhance product performance, and / or improve texture. It can also be loaded with other molecules of interest, such as dyes, fragrances or actives, for example to prolong their persistence on skin, hair, or nails.

[0015] SUMMARY OF THE INVENTION

[0016] In a first aspect, the present invention relates to a cosmetic composition comprising a filmforming, water-soluble structural protein.

[0017] In a second aspect, the present invention relates to the use of the cosmetic composition of the first aspect in personal care.

[0018] In a third aspect, the present invention relates to the use of the cosmetic composition of the first aspect for skin, hair, or nail coating.

[0019] In a fourth aspect, the present invention relates to the use of the cosmetic composition of the first aspect for skin, hair, or nail repair.

[0020] In a fifth aspect, the present invention relates to the use of the cosmetic composition of the first aspect for skin, hair, or nail protection.In a sixth aspect, the present invention relates to the use of the cosmetic composition of the first aspect to fix one or more cosmetic ingredients to skin, hair, nails, and / or mucosa.

[0021] In a seventh aspect, the present invention relates to a coating / film made from / comprising the cosmetic composition of the first aspect.

[0022] This summary of the invention does not necessarily describe all features of the present invention. Other embodiments will become apparent from a review of the ensuing detailed description.

[0023] DETAILED DESCRIPTION OF THE INVENTION

[0024] Definitions

[0025] Before the present invention is described in detail below, it is to be understood that this invention is not limited to the particular methodology, protocols and reagents described herein as these may vary. It is also to be understood that the terminology used herein is for the purpose of describing embodiments only and is not intended to limit the scope of the present invention which will be limited only by the appended claims. Unless defined otherwise, all technical and scientific terms used herein have the same meanings as commonly understood by one of ordinary skill in the art.

[0026] Preferably, the terms used herein are defined as described in “A multilingual glossary of biotechnological terms: (TUPAC Recommendations)”, Leuenberger, H.G.W, Nagel, B. and Kolbl, H. eds. (1995), Helvetica Chimica Acta, CH-4010 Basel, Switzerland).

[0027] Several documents are cited throughout the text of this specification. Each of the documents cited herein (including all patents, patent applications, scientific publications, manufacturer's specifications, instructions, GenBank Accession Number sequence submissions etc.), whether supra or infra, is hereby incorporated by reference in its entirety. Nothing herein is to be construed as an admission that the invention is not entitled to antedate such disclosure by virtue of prior invention.

[0028] In the following, the elements of the present invention will be described. These elements are listed with specific embodiments; however, it should be understood that they may be combined in any manner and in any number to create additional embodiments. The variously described examples and preferred embodiments should not be construed to limit the present invention to only the explicitly described embodiments. This description should be understood to support and encompass embodiments which combine the explicitly described embodiments with any number of the disclosed and / or preferred elements. Furthermore, any permutations and combinations of alldescribed elements in this application should be considered disclosed by the description of the present application unless the context indicates otherwise.

[0029] The term “comprise” or variations such as “comprises” or “comprising” according to the present invention means the inclusion of a stated integer or group of integers but not the exclusion of any other integer or group of integers. The term “consisting essentially of’ according to the present invention means the inclusion of a stated integer or group of integers, while excluding modifications or other integers which would materially affect or alter the stated integer. The term “consisting of’ or variations such as “consists of’ according to the present invention means the inclusion of a stated integer or group of integers and the exclusion of any other integer or group of integers.

[0030] The terms “a” and “an” and “the” and similar reference used in the context of describing the invention (especially in the context of the claims) are to be construed to cover both the singular and the plural, unless otherwise indicated herein or clearly contradicted by context.

[0031] The term “about” when used in connection with a numerical value is meant to encompass numerical values within a range having a lower limit that is 5% smaller than the indicated numerical value and having an upper limit that is 5% larger than the indicated numerical value (i.e. ± 5%).

[0032] The terms “polypeptide” and “protein” are used interchangeably in the context of the present invention. They refer to a long peptide-linked chain of amino acids, e.g. one that is at least 20 amino acids long.

[0033] As mentioned above, the present inventors provide herewith a cosmetic composition comprising a film-forming, water-soluble structural protein. This cosmetic composition can be used in personal care.

[0034] The term “cosmetics”, as used herein, refers to products or substances applied to the body, particularly the skin, hair, or nails, to enhance appearance, cleanse, and / or provide a sensory benefit. Cosmetics include a wide range of beauty and personal care products but do not claim to alter or treat medical conditions. Common types of cosmetics include, but are not limited to, skin care (e.g. moisturizers, serums, or sunscreen), makeup / colour cosmetics (e.g. foundation, lipstick, or mascara), hair care (e.g. shampoo, conditioner, or styling products), fragrances (e.g. perfume, body sprays), or hygiene produces (e.g. soaps, deodorants). Cosmetics are regulated to ensure safety and effectiveness but are distinct from pharmaceuticals, as they primarily focus on aesthetic improvement. The cosmetics as described herein are not only used for humans but also for animal care. Usually, cosmetics are provided in form of a cosmetic composition.

[0035] The term “cosmetic composition”, as used herein, refers to a composition developed for application to the skin, hair, nails, or body to enhance appearance, cleanse, or provide a sensorybenefit. These compositions are found in skin care, hair care, makeup / colour cosmetics, and / or hygiene products. The cosmetic composition as described herein is not only used for humans but also for animal care.

[0036] The term “personal care”, as used herein, refers to the practice of maintaining hygiene, grooming, and / or overall well-being using various products and routines. Personal care includes, but is not limited to, skin care (e.g. moisturizers, cleansers, or sunscreen), hair care (e.g. shampoo, conditioner, or styling products), oral care (e.g. toothpaste, mouthwash, floss), hygiene (e.g. soap, deodorant, or body wash), grooming (e.g. shaving products, or perfumes), colour cosmetics, and body care to enhance cleanliness, health, and appearance. Personal care can be part of daily routines and is influenced by health, culture, and personal preferences.

[0037] The personal care includes human care and animal care. If animal care is meant, hair and coat care is also encompassed.

[0038] The term “personal care composition”, as used herein, refers to a composition designed for application to the body, skin, or hair to maintain hygiene, improve appearance, and / or improve overall well-being.

[0039] The term “skin care composition”, as used herein, refers to a composition that is applied to skin in order to provide beneficial properties, including, but not limited to, wrinkle minimizing, wrinkle removal, colouring, skin softening, skin smoothing, depilation, cleansing, relubricating dry skin, compensating the loss of lipid and water caused by daily washing, delay skin aging etc. The skin care composition as described herein may improve skin appearance. The skin appearance improvement may comprise lessening of wrinkles, smoothing skin texture, moisturizing skin, and other desired cosmetic benefits.

[0040] The term “hair care composition”, as used herein, refers to a composition that is applied to hair in order to provide beneficial properties, including, but not limited to, texture improvement, smoothness improvement, shine improvement, repair, and protective performance against thermally or chemically induced damages.

[0041] The term “hair care composition” includes both leave-in products and rinse-off products. For example, there are hair cleansing compositions, hair conditioning compositions, and hair styling compositions, such as shampoos, conditioners, sprays, treatments, masks, strengtheners, preshampoos, lotions, serums, creams, foams, mousses, and gels. Many of these compositions that are known are water-based formulations.

[0042] The hair care composition as described herein may improve hair appearance. The hair appearance improvement may comprise shine and smoothness improvement.

[0043] The term “structural protein”, as used herein, refers to a protein having an amino acid sequence comprising regularly recurring clusters of amino acids. Such clusters can also bedesignated as repeat units / domains. The consequence of this regular primary structure is a secondary structure arranged in longer areas, for example, as a right-handed a-helix (in a-keratin) or as a narrow left-handed a-helix (in collagen) or as a P-sheet (in P-keratin or in the fibroin of insect silk) or as alternating crystalline and amorphous areas (in the fibroin of spider silk).

[0044] As mentioned above, the structural protein of the present invention is a film-forming water-soluble protein. This protein was designed by combining Al-based computational tools, proprietary high throughput material property screening methods and microbial manufacturing. It is, thus, a synthetic protein. Preferably, the structural protein is a (synthetic) beta solenoid protein.

[0045] The term “beta solenoid protein”, as used herein, refers to a type of protein structure characterized by blocks of nearly identical amino acid domains (repeat units) and blocks of variable amino acid domains (repeat units) which alternate with each other. The term “beta solenoid protein”, as used herein, further refers to a protein having a series of beta-strands that twist around each other to form a cylindrical, solenoid-like shape.

[0046] Specifically, beta solenoid proteins are primarily composed of beta-strands, which are extended polypeptide chains that align side-by-side to form a sheet-like structure. In a beta solenoid, these strands are arranged in a specific, repeated pattern that spirals around a central axis.

[0047] The repeating beta-strands form a spiral or helical structure, like a solenoid, which is a cylindrical, coil-like shape. This folding pattern allows the protein to create a stable, compact structure, with the strands wrapping around one another multiple times.

[0048] The repeating nature of the beta strands and their interactions (like hydrogen bonds) make beta solenoid proteins particularly stable.

[0049] The term “water-soluble protein”, as used herein, refers to a type of protein that can dissolve in water or aqueous solutions. These proteins typically have hydrophilic (water-attracting) regions on their surface that enable them to interact with water molecules, allowing them to remain dissolved. This contrasts with water-insoluble proteins, which tend to aggregate or form solid structures in the presence of water.

[0050] The solubility of proteins often depends on their amino acid composition, with hydrophilic amino acids contributing to their ability to dissolve in water.

[0051] There are no universal, fixed thresholds for water solubility that apply in all fields. The solubility of a substance depends on various factors such as its chemical structure, temperature, pH, and the type of solvent. However, there are general guidelines used in chemistry and pharmacy to classify the solubility of a substance:

[0052] Very soluble: Substances that can dissolve in more than 1000 g / 1 (kg / m3) of water at room temperature.

[0053] Freely soluble: Substances that can dissolve in 10 to 1000 g / 1 (kg / m3) of water.Slightly soluble: Substances that can dissolve in 1 to 10 g / 1 (kg / m3) of water.

[0054] Very slightly soluble: Substances that can dissolve in less than 1 g / 1 (kg / m3) of water.

[0055] The water-soluble structural protein of the present invention has preferably a water solubility of more than 1 g / 1 (kg / m3), e.g. of more than 20 g / 1 (kg / m3). More preferably, the structural protein has a water solubility of between 1 and 450 g / 1 (kg / m3), e.g. of between 150 and 400 g / 1 (kg / m3).

[0056] The term “film-forming protein”, as used herein, refers to a type of protein that, when dissolved in a suitable medium (such as water), can create a thin, continuous layer or film on a surface. A film-forming protein is, therefore, able to form protective coatings, improve texture, and enhance stability. In cosmetics, a film-forming protein can be used in compositions such as lotions or hair care products to create smooth, even coverage on the skin or hair. The ability of a film-forming protein to form films may be attributable to its molecular structure, which allows to interact with proteins of the same type and to bind to surfaces, forming a cohesive layer.

[0057] The term “coating”, as used herein, refers to a covering that is applied to a substrate, in particular to the surface of a substrate, to be coated. The coating itself may be an all-over coating, completely covering the substrate, or it may only cover parts of the substrate. Preferably, the coating covers the surface to be treated. The coating may be applied via spreading, rinsing, or spraying. On skin, the coating is nearly invisible.

[0058] The term “cosmetic ingredient”, as used herein, refers to any compound having a cosmetic benefit.

[0059] The term “cosmetic benefit”, as used herein, refers to a desired cosmetic change that results from the administration of the cosmetic composition of the present invention. Cosmetic benefits include, but are not limited to, improvements in the condition of skin, hair, nail, and the oral cavity. In preferred embodiments, at least one cosmetic benefit is provided by the skin care, oral care, hair care, nail care and makeup compositions of the present disclosure.

[0060] In other words, the term “cosmetic ingredient”, as used herein, refer to any substance or compound used in the formulation of cosmetic products to provide specific functional, sensory, or aesthetic benefits. These ingredients can be of natural, synthetic, or semi-synthetic origin and serve various purposes such as cleansing, moisturizing, preserving, colouring, or enhancing the texture of cosmetic products.

[0061] The term “cosmetic carrier”, as used herein, refers to any cosmetically acceptable material forming the carrier of the active ingredients in the cosmetic composition. A typical carrier material is, for example, water or an aqueous solution.

[0062] The term “cosmetically acceptable”, as used herein, refers to any ingredient, formulation, or product that meets safety, efficacy, and sensory standards for use in cosmetic applications. This means the ingredient or product should be non-toxic, non-irritating, stable, and pleasant to use,while also complying with regulatory guidelines (e.g. FDA in the United States, EU Regulation (EC) No 1223 / 2009, Japan's MHLW, and China's NMPA).

[0063] The term “functional equivalents”, as used herein, refers to variants obtainable by one or more amino acid additions, substitutions, deletions, and / or inversions, which changes may occur in any amino acid sequence position as long as they result in a variant having the property profile of the structural protein of the invention. Equivalence is especially given when the reactivity patterns between variant and unchanged polypeptide match qualitatively.

[0064] The variants of the structural protein of the present invention preferably encompass such functional equivalents. Below are amino acids grouped based on their chemical and structural properties, indicating which ones can specifically be replaced with no or minimal functional impact.

[0065] 1. Hydrophobic (Non-Polar) Amino Acids (Aliphatic and Aromatic)

[0066]

[0067] 2. Polar (Uncharged) Amino Acids

[0068]

[0069] 3. Charged Amino Acids (Acidic and Basic)

[0070] Acidic (Negatively Charged)

[0071]

[0072] Basic (Positively Charged)

[0073]

[0074] Embodiments of the invention

[0075] The present invention will now be further described. In the following passages, different aspects of the invention are defined in more detail. Each aspect so defined may be combined with any other aspect or aspects unless clearly indicated to the contrary. In particular, any feature indicated as being preferred or advantageous may be combined with any other feature or features indicated as being preferred or advantageous, unless clearly indicated to the contrary.

[0076] The present inventors provide herewith a cosmetic composition comprising a new filmforming, water-soluble structural protein. This protein was designed by combining Al-based computational tools, proprietary high throughput material property screening methods and microbial manufacturing. With a fermentation approach, the artificial, computer generated, and non-animal derived protein was produced in large-scale and tested in cosmetic applications.

[0077] The present inventors could show that the new water-soluble structural protein has the ability to form a thin, continuous layer or film on the skin, hair, or mucosa when applied. It is used to create a protective barrier, enhance product performance, and / or improve texture.

[0078] Thus, in a first aspect, the present invention relates to a cosmetic composition comprising a film-forming, water-soluble structural protein.

[0079] Specifically, the structural protein is a synthetic protein.

[0080] In one embodiment, the structural protein has a size of at least 20 kDa. Preferably, the structural protein has a size of at least 80 kDa. More preferably, the structural protein has a size of at least 100 kDa. For example, the structural protein has a size of at least 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102,103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 181, 182, 183, 184, 185, 186, 187, 188, 189, 190, 191, 192, 193, 194, 195, 196, 197, 198, 199, or 200 kDa.

[0081] In one another embodiment, the structural protein has a size of between 20 and 200 kDa. Preferably, the structural protein has a size of between 80 and 200 kDa. More preferably, the structural protein has a size of between 90 and 120 kDa. For example, the structural protein has a size of 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 181, 182, 183, 184, 185, 186, 187, 188, 189, 190, 191, 192, 193, 194, 195, 196, 197, 198, 199, or 200 kDa.

[0082] In particular, the structural protein has a size of about 104 kDa (L6 or B2).

[0083] In one (alternative or additional) embodiment, the structural protein has a water solubility of more than 1 g / 1 (kg / m3). Preferably, the structural protein has a water solubility of more than 20 g / 1 (kg / m3). More preferably, the structural protein has a water solubility of more than 40 g / 1 (kg / m3). Even more preferably, the structural protein has a water solubility of more than 100 g / 1 (kg / m3). For example, the structural protein has a water solubility of more than 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 181, 182, 183, 184, 185, 186, 187, 188, 189, 190, 191, 192, 193, 194, 195, 196, 197, 198, 199, 200, 210, 220, 230, 240, 250, 260, 270, 280, 290, 300, 310, 320, 330, 340, 350, 360, 370, 380, 390, or 400 g / 1 (kg / m3).In one another embodiment, the structural protein has a water solubility of between 1 and 450 g / 1 (kg / m3). Preferably, the structural protein has a water solubility of between 10 and 400 g / 1 (kg / m3). More preferably, the structural protein has a water solubility of between 30 and 400 g / 1 (kg / m3). Even more preferably, the structural protein has a water solubility of between 50 and 400 g / 1 (kg / m3). Still even more preferably, the structural protein has a water solubility of between 150 and 400 g / 1 (kg / m3). For example, the structural protein has a water solubility of 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 181, 182, 183, 184, 185, 186, 187, 188, 189, 190, 191, 192, 193, 194, 195, 196, 197, 198, 199, 200, 210, 220, 230, 240, 250, 260, 270, 280, 290, 300, 310, 320, 330, 340, 350, 360, 370, 380, 390, 400, 410, 420, 430, 440, or 450 g / 1 (kg / m3).

[0084] Particularly, the structural protein has a size of between 80 and 200 kDa and a water solubility of between 40 and 400 g / 1 (kg / m3). More particularly, the structural protein has a size of between 90 and 120 kDa and a water solubility of between 50 and 400 g / 1 (kg / m3).

[0085] The structural protein of the present invention is capable of forming a thin continuous film / coating on surfaces without penetrating them. The surfaces may be selected from the group consisting of skin, hair, and mucosa. In this respect, it should be noted that the structural protein of the present invention has the ability to form a thin, continuous layer or film on the skin, hair, or mucosa when applied. It is used to create a protective barrier, enhance product performance, and / or improve texture. The structural protein of the present invention has also good adhesion properties, is flexible, and improves texture.

[0086] The cosmetic composition as described herein may comprise an aqueous or gel phase. Specifically, the cosmetic composition is in powder, liquid, or gel form.

[0087] In one further (alternative or additional) embodiment, the concentration of the structural protein in the composition is in the range of between 0.01 wt% / vol and 50 wt% / vol, e.g. 0.01, 0.02, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.09, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, or 50 wt% / vol. Preferably, the concentration of the structural protein in the composition is in the range of between 0.01 wt% / voland 30 wt% / vol, e.g. 0.01, 0.02, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.09, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, or 30 wt% / vol. More preferably, the concentration of the structural protein in the composition is in the range of between 0.01 wt% / vol and 20 wt% / vol, e.g. 0.01, 0.02, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.09, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 20 wt% / vol. Even more preferably, the concentration of the structural protein in the composition is in the range of between 0.01 wt% / vol and 2 wt% / vol, e.g. e.g. 0.01, 0.02, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.09, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1, 1.5, or 2 wt% / vol. In one specific example, the concentration of the structural protein in the composition is 0.06 wt% / vol.

[0088] Particularly, the structural protein has a concentration of between 0.01 wt% / vol and 20 wt% / vol in the cosmetic composition, a size of between 80 and 200 kDa, and a water solubility of between 40 and 400 g / 1 (kg / m3). More particularly, the structural protein has a concentration of between 0.01 wt% / vol and 2 wt% / vol in the cosmetic composition, a size of between 90 and 120 kDa, and a water solubility of between 50 and 400 g / 1 (kg / m3).

[0089] The structural protein may be a protein as described in WO 2019 / 175591 Al, which is hereby incorporated by reference in its entirety.

[0090] In one preferred embodiment, the structural protein comprises

[0091] (a) at least one repeat unit, preferably 2, 3, 4, or 5 repeat units, comprising at least one (e.g. 1, 2, or 3) of the following modules: module A having an amino acid sequence according to SEQ ID NO: 1, module B having an amino acid sequence according to SEQ ID NO: 2, and module C having an amino acid sequence according to SEQ ID NO: 3, and / or

[0092] (b) at least one repeat domain, preferably 2, 3, or 4 repeat domains, comprising at least five (e.g.

[0093] 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, or 25) repeats of the following motif: A (N / D) L * X (SEQ ID NO: 4), wherein * is a polar amino acid residue, preferably selected from the group consisting of C, R, H, K, D, E, S, T, N, and Q, and X is any amino acid residue.

[0094] For example, the structural protein comprises

[0095] (a) 5 repeat units, comprising 2 or 3 of the following modules: module A having an amino acid sequence according to SEQ ID NO: 1, module B having an amino acid sequence according to SEQ ID NO: 2, and module C having an amino acid sequence according to SEQ ID NO: 3, and / or

[0096] (b) at least 4 repeat domains, comprising at least five (e.g. 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, or 25) repeats of the following motif: A (N / D) L * X (SEQID NO: 4), wherein * is a polar amino acid residue, preferably selected from the group consisting of C, R, H, K, D, E, S, T, N, and Q, and X is any amino acid residue.

[0097] Module A has the following an amino acid sequence: ARTTGARLDDADLRGATVDPVLWRTASLRGAKMEEEQRREYERARG (SEQ ID NO: 1). Module B has the following an amino acid sequence: GGQGGQGGSGGSAAAAAAAAGGSGGSGGQGGQ (SEQ ID NO: 2).

[0098] Module C has the following an amino acid sequence: RMRRDEILEEYRRGRRNFQHINLQEIELTN (SEQ ID NO: 3).

[0099] Also fragments of the amino acid sequence according to SEQ ID NO: 1 to SEQ ID NO: 3 and variants of the amino acid sequence according to SEQ ID NO: 1 to SEQ ID NO: 3 are encompassed by the present invention.

[0100] Specifically, the module fragments are between 1 and 6, preferably between 1 and 4, e.g. 1, 2, 3, 4, 5, or 6, amino acids shorter than the amino acid sequence according to SEQ ID NO: 1 to SEQ ID NO: 3. The deletion can be N-terminal, C-terminal, and / or internal.

[0101] Specifically, the module variants have at least 80%, preferably at least 85%, more preferably at least 90%, and most preferably at least 95% or 99%, e.g. at least 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, or 99%, sequence identity to the amino acid sequence according to SEQ ID NO: 1 to SEQ ID NO: 3.

[0102] In the variants, amino acids are preferably replaced by other chemically similar amino acids without significantly affecting the functional properties of the protein. These replacements are known as conservative substitutions tolerated in protein structure and function. Preferred functional equivalents are listed in the tables above (see definition part).

[0103] In this respect, it should be noted that a module variant or fragment is only regarded as module variant or fragment within the context of the present invention, if the modifications with respect to the amino acid sequence on which the variant or fragment is based do not negatively affect the water-solubility of the structural protein and the ability of the structural protein to form a thin continuous film / coating on surfaces (e.g. skin, hair or mucosa) without penetrating them. The skilled person can readily assess whether these properties are still present (see experimental section).

[0104] In one more preferred embodiment, module A is 4 times comprised in the structural protein, module B is 5 times comprised in the structural protein, and / or module C is 4 times comprised in the structural protein.

[0105] In one even more preferred embodiment, the repeat unit(s) comprise the modules (i) A and B, (ii) B and C, (iii) A and C, or (iv) A, B, and C in any order.Specifically, the structural protein comprises an amino acid sequence comprising modules B, C, A, B, C, A, B, C, A, B, C, A, and B in this order.

[0106] In one still even more preferred embodiment, the repeat unit(s) is (are independently) selected from the group consisting of SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, a fragment thereof, and a sequence having at least 80% sequence identity thereto.

[0107] The repeat unit according to SEQ ID NO: 5 (B module + C module) has the following amino acid sequence:

[0108] GGQGGQGGSGGSAAAAAAAAGGSGGSGGQGGQRMRRDEILEEYRRGRRNFQHINLQE IELTN.

[0109] The repeat unit according to SEQ ID NO: 6 (A module + B module + C module) has the following amino acid sequence:

[0110] ARTTGARLDDADLRGATVDPVLWRTASLRGAKMEEEQRREYERARGGGQGGQGGSG GSAAAAAAAAGGSGGSGGQGGQRMRRDEILEEYRRGRRNFQHINLQEIELTN.

[0111] The repeat unit according to SEQ ID NO: 7 (A module + B module) has the following amino acid sequence:

[0112] ARTTGARLDDADLRGATVDPVLWRTASLRGAKMEEEQRREYERARGGGQGGQGGSG GSAAAAAAAAGGSGGSGGQGGQ.

[0113] Specifically, the structural protein has an amino acid sequence comprising repeat units according to SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 6, SEQ ID NO: 6, and SEQ ID NO: 7 in this order. As mentioned above, also fragments of the amino acid sequence according to SEQ ID NO: 5 to SEQ ID NO: 7 and variants of the amino acid sequence according to SEQ ID NO: 5 to SEQ ID NO: 7 are encompassed by the present invention.

[0114] Specifically, the repeat unit fragments are between 1 and 10, preferably between 1 and 6, e.g. 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10, amino acids shorter than the amino acid sequence according to SEQ ID NO: 5 to SEQ ID NO: 7. The deletion can be N-terminal, C-terminal, and / or internal.

[0115] Specifically, the repeat unit variants have at least 80%, preferably at least 85%, more preferably at least 90%, and most preferably at least 95% or 99%, e.g. at least 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, or 99%, sequence identity to the amino acid sequence according to SEQ ID NO: 5 to SEQ ID NO: 7.

[0116] In the variants, amino acids are preferably replaced by other chemically similar amino acids without significantly affecting the functional properties of the protein. These replacements are known as conservative substitutions tolerated in protein structure and function. Preferred functional equivalents are listed in the tables above (see definition part).

[0117] In this respect, it should be noted that a module variant or fragment is only regarded as module variant or fragment within the context of the present invention, if the modifications with respectto the amino acid sequence on which the variant or fragment is based do not negatively affect the water-solubility of the structural protein and the ability of the structural protein to form a thin continuous film / coating on surfaces (e.g. skin, hair or mucosa) without penetrating them. The skilled person can readily assess whether these properties are still present (see experimental section).

[0118] In one another (alternative or additional) more preferred embodiment, the repeat domain(s) are independently selected from the group consisting of SEQ ID NO: 8, SEQ ID NO: 9, a fragment thereof, and a sequence having at least 80% sequence identity thereto.

[0119] In one another (alternative or additional) even more preferred embodiment, the amino acid sequence according to SEQ ID NO: 8 is 4 times comprised in the structural protein of the present invention, or the amino acid sequence according to SEQ ID NO: 9 is 4 times comprised in the structural protein of the present invention.

[0120] The repeat domain according to SEQ ID NO: 8 has the following amino acid sequence: ASLTGADLSYANLHHANLSRANLRSADLRNANLSHANLSGANLEEANLEAANLRGADL HEANLSGADLQEANLTQANLKDANLSDANLEQADLAGADLQGAVLDGANLHGANLN NANLSEAMLTRANLEQADLSG, or

[0121] the repeat domain according to SEQ ID NO: 9 has the following amino acid sequence:

[0122] ANLSEASLDGADLEGAMLQDANLSYANLQGADLSEADLEDANLSGANLKNANLSGAN LTGANLHSANLNAANLSQANLRQAVLAGANLTEANLEEANLHRADLHGANLRGADLS GANLEQADLSNANLRRADLTH.

[0123] As mentioned above, also fragments of the amino acid sequence according to SEQ ID NO: 8 or SEQ ID NO: 9 and variants of the amino acid sequence according to SEQ ID NO: 8 or SEQ ID NO: 9 are encompassed by the present invention.

[0124] Specifically, the repeat domain fragments are between 1 and 10, preferably between 1 and 6, e.g.

[0125] 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10, amino acids shorter than the amino acid sequence according to SEQ ID NO: 8 or SEQ ID NO: 9. The deletion can be N-terminal, C-terminal, and / or internal.

[0126] Specifically, the repeat domain variants have at least 80%, preferably at least 85%, more preferably at least 90%, and most preferably at least 95% or 99%, e.g. at least 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, or 99%, sequence identity to the amino acid sequence according to SEQ ID NO: 8 or SEQ ID NO: 9.

[0127] In the variants, amino acids are preferably replaced by other chemically similar amino acids without significantly affecting the functional properties of the protein. These replacements are known as conservative substitutions tolerated in protein structure and function. Preferred functional equivalents are listed in the tables above (see definition part).In this respect, it should be noted that a module variant or fragment is only regarded as module variant or fragment within the context of the present invention, if the modifications with respect to the amino acid sequence on which the variant or fragment is based do not negatively affect the water-solubility of the structural protein and the ability of the structural protein to form a thin continuous film / coating on surfaces (e.g. skin, hair or mucosa) without penetrating them. The skilled person can readily assess whether these properties are still present (see experimental section).

[0128] Particularly, the structural protein comprises an amino acid sequence comprising repeat units according to SEQ ID NO: 5, SEQ ID NO: 6, and SEQ ID NO: 7 and repeat domains according to SEQ ID NO: 8 or SEQ ID NO: 9. More particularly, the structural protein comprises an amino acid sequence comprising one repeat unit according to SEQ ID NO: 5, three repeat units according to SEQ ID NO: 6, and one repeat unit according to SEQ ID NO: 7 as well as four repeat domains according to SEQ ID NO: 8 or SEQ ID NO: 9.

[0129] In one most preferred embodiment, the structural protein has an amino acid sequence according to SEQ ID NO: 10 (L6) or SEQ ID NO: 11 (B2).

[0130] Also fragments of the amino acid sequence according to SEQ ID NO: 10 or SEQ ID NO: 11 and variants of the amino acid sequence according to SEQ ID NO: 10 to SEQ ID NO: 11 are encompassed by the present invention.

[0131] Specifically, the structural protein fragments are between 1 and 20, preferably between 1 and 10, e.g. 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 20, amino acids shorter than the amino acid sequence according to SEQ ID NO: 10 or SEQ ID NO: 11. The deletion can be N-terminal, C-terminal, and / or internal.

[0132] Specifically, the structural protein variants have at least 80%, preferably at least 85%, more preferably at least 90%, and most preferably at least 95% or 99%, e.g. at least 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, or 99%, sequence identity to the amino acid sequence according to SEQ ID NO: 10 or SEQ ID NO: 11.

[0133] In the variants, amino acids are preferably replaced by other chemically similar amino acids without significantly affecting the functional properties of the protein. These replacements are known as conservative substitutions tolerated in protein structure and function. Preferred functional equivalents are listed in the tables above (definition part).

[0134] In this respect, it should be noted that a module variant or fragment is only regarded as module variant or fragment within the context of the present invention, if the modifications with respect to the amino acid sequence on which the variant or fragment is based do not negatively affect the water-solubility of the structural protein and the ability of the structural protein to form a thin continuous film / coating on surfaces (e.g. skin, hair or mucosa) without penetrating them.The skilled person can readily assess whether these properties are still present (see experimental section).

[0135] Preferably, the cosmetic composition is / is formulated as an oral care composition, a skin care composition, a sanitizing composition, a hair care composition, a makeup composition, a sun care composition, a deodorant, an antiperspirant composition, a nail cosmetic composition, a skin cleansing composition, an aromatic cosmetic, or a bath cosmetic composition.

[0136] More preferably, the cosmetic composition is / is formulated as cosmetic care product selected from the group consisting of an insect repellent, a beauty soap, a soap bar, a soap solution, a soap gel, a facial wash, a hand wash, a body wash, a hand sanitizer, a cleansing wipe, a feminine hygiene product, a cleansing pad, a cleansing foam, a rinse, a cleansing lotion, a cleansing milk, a cleansing gel, a cleansing soap bar, an exfoliating product, a bath and shower soap in bar, a cream, an emulsion, a shaving or after-shave cream, a foam, a conditioner, a cologne, a shaving or aftershave lotion, a perfume, a cosmetic oil, a facial mask, a moisturizer, an anti-wrinkle, an eye treatment, a tanning cream, a tanning lotion, a tanning emulsion, a sunscreen cream, a sunscreen lotion, a sunscreen emulsion, a tanning oil, a sunscreen oil, a hand lotion, a body lotion, a colour cosmetic, a mascara, a lipstick, a lip liner, an eye shadow, an eye-liner, a rouge, a face powder, a foundation, a blush, bath product, a toothpaste, a dentifrice, a tooth powder, an oral gel, an aqueous gel, a non- aqueous gel, a mouth rinse, a mouth spray, a plaque removing liquid, a denture product, a dental solution, a lozenge, oral tablet, a chewing gum, a candy, a fast-dissolving film, a strip, a dental floss, a tooth glossing product, a finishing product, an impregnated dental implement, a remineralizing gel, a remineralizing mouthwash, a remineralizing tooth powder, a remineralizing chewing gum, a remineralizing lozenge, a remineralizing toothpaste, a antiperspirant stick, a roll on deodorant, a powder deodorant, a gel deodorant, an aerosol deodorant, a paste deodorant, a cream nail polish, and a nail polish remover.

[0137] The cosmetic composition may further comprise one or more cosmetic ingredi ents / compounds .

[0138] The cosmetic ingredi ent / compound can be any ingredient / compound having a cosmetic benefit.

[0139] The cosmetic ingredients can be, for example, proteinaceous molecules, such as other structural proteins, enzymes or antibodies, or non-proteinaceous molecules, such as dyes, pigments, photoprotective agents, vitamins, provitamins, antioxidants, conditioners or compounds comprising metal ions.

[0140] Among the proteinaceous molecules, other structural proteins, enzymes and antibodies are preferred.The other structural proteins are preferably selected from the group consisting of silk proteins, keratin, and collagen. More preferably, the structural protein of the present invention is mixed with / used together with one or more silk proteins.

[0141] Other useful examples include, but are not limited to, oxidases, peroxidases, proteases, glucanases, mutanase, tyrosinases, laccases, metal-binding enzymes, lactoperoxidase, lysozyme, aminoglycosidase, glucose oxidase, superoxide dismutase, photolyase, T4 endonuclease, catalase, thioredoxin or thioredoxin-reductase.

[0142] Also preferable are proteinaceous substances which do not possess an enzymatic function. Examples for non-enzymatic proteinaceous molecules include, but are not limited to, antimicrobial peptides, hydrophobins, collagen, proteins binding carotenoid, proteins binding heavy metals, proteins binding odorants, proteins binding cellulose, proteins binding starch, or proteins binding keratin.

[0143] The cosmetic ingredient / compound can further be a UV-protective filter. This is by definition an organic substance which can absorb specific wavelengths in the range of UV-wavelengths. The absorbed energy can then be emitted in the form of longer wave radiation, e.g. heat.

[0144] Examples of suitable water-soluble UV-protective filters include, but are not limited to, 2-phenyl-benzimidazole-5-sulfonic acid and the alkali metal, alkaline earth metal, ammonium, alkylammonium, alkanol ammonium and glucammonium salts thereof, sulfonic acid derivatives of benzophones such as 2-hydroxxy-4-methoxybenzophene-5-sulfonic acid and its salts, sulfonic acid derivatives of 3 -benzylidenecamphor such as 4-(2-oxo-3-bornylidene-methyl)benzenesulfonic acid and 2-methyl-5-(2-oxo-3-bomylidene)-sulfonic acid and salts thereof, esters of cinnamic acid such as 2-ethylhexyl 4-methoxycinnamate, isopentyl 4-methoxycinnamate or 2-ethylhexyl 2-cyano-3 -phenyl cinnamate (octocrylene), derivatives of benzophene such as 2-hydroxy-4-methoxybenzophne, 2-hydroxy-4-methoxy-4’ -methyl -benzophenone, 2, 2’-dihydroxy-4-methoxybenzophenone or propane- 1,3 -di ones such as l-(4-tert-butylphenyl)-3 -(4’ -methoxyphenyl)propane- 1 ,3 -di one.

[0145] The cosmetic ingredient / compound may also comprise a secondary protective agent of the antioxidant type which interrupts the photochemical reaction chain triggered by UV radiation when penetrating into the skin. Typical examples include, but are not limited to, super oxide dismutase, catalase, tocopherols (vitamin E), coenzyme Q10, ubiquinanes, quiniones and ascorbic acid (vitamin C).

[0146] The cosmetic ingredient / compound can also be a vitamin, a provitamin, or precursors thereof. Examples include, but are not limited to, P-carotene (provitamin of vitamin A), ascorbic acid (vitamin C), tocopherols, the vitamins, provitamins or precursors of the vitamin B group orderivatives thereof such as vitamin Bi (thiamine), vitamin B2 (riboflavin) or the stereoisomer lyxoflavin, vitamin B3 (nicotinic acid or nicotinamid), vitamin B5 (panthothenic acid and panthenol) and derivatives thereof such as esters, ethers and cationically derivatized panthenol, derivatives of 2-furanone such as dihydro-3 -hydroxy-4, 4-dimethyl-2(3H)-furanone (pantolactone), 4-hydroxymethyl-y-butyrolactone, 3, 3 -dimethyl -2-hydroxy- y-butyrolactone and 2,5-dihydro-5-methoxy-2-furanone and stereoisomers thereof, vitamin Be such as derivatives of 5-hydroxymethyl-2-methylpyridin-3-ol (also known as pyridoxine, pyridoasamine or pyridoxal) and vitamin B7 (biotin).

[0147] Specifically, the one or more cosmetic ingredients / compounds are selected from the group consisting of actives, functionals, pigments, dyes, fragrances, enzymes, coenzyme, vitamins, hyaluronic acid, peptides, amino acids, ceramides, probiotics, UV protective agents, and antioxidants.

[0148] The cosmetic composition may also comprise one or more cosmetic carriers.

[0149] The cosmetic carrier is any cosmetically acceptable material forming the basis for the cosmetic ingredients. For example, the one or more cosmetic carriers are selected from the group consisting of water, liposomes, gels, and polymers.

[0150] Preferably, the cosmetic composition of the first aspect is a skin care composition or a hair care composition.

[0151] The skin care composition is any composition that is applied to skin to provide beneficial properties, including, but not limited to, wrinkle minimizing, wrinkle removal, decoloring, coloring, skin softening, skin smoothing, depilation, cleansing, relubricating dry skin, compensating the loss of lipid and water caused by daily washing, delay skin aging etc. In some embodiments, this disclosure provides a skin care composition that improve skin tone. In these embodiments, the skin tone improvement comprises lessening of wrinkles, smoothing skin texture, moisturizing skin, and other desired cosmetic benefits.

[0152] The hair care is any composition that is applied to hair to provide beneficial properties, including, but not limited to texture improvement, smoothness improvement, shine improvement, repair, and protective performance against thermally or chemically induced damages.

[0153] The hair care composition includes both leave-in products and rinse-off products. For example, there are hair cleansing compositions, hair conditioning compositions, and hair styling compositions, such as shampoos, conditioners, sprays, treatments, masks, strengtheners, preshampoos, lotions, serums, creams, foams, mousses, and gels. Many of these compositions that are known are water-based formulations.

[0154] In a second aspect, the present invention relates to the use of the cosmetic composition of the first aspect in personal care.Personal care refers to the practice of maintaining hygiene, grooming, and / or overall well-being using various products and routines. Personal care includes, but is not limited to, skin care (e.g. moisturizers, cleansers, or sunscreen), hair care (e.g. shampoo, conditioner, or styling products), oral care (e.g. toothpaste, mouthwash, floss), hygiene (e.g. soap, deodorant, or body wash), grooming (e.g. shaving products, or perfumes), colour cosmetics, nail care (e.g. nail polish, nail oil, or nail cream), and body care to enhance cleanliness, health, and appearance. Personal care can be part of daily routines and is influenced by health, culture, and personal preferences.

[0155] Personal care includes human care and animal care. If animal care is meant, hair and coat care is also encompassed.

[0156] Preferably, personal care is skin care, hair care, nail care, or colour cosmetics.

[0157] In a third aspect, the present invention relates to the use of the cosmetic composition of the first aspect for skin, hair, or nail coating.

[0158] As mentioned above, the structural protein forms a film / coating on surfaces without penetrating them. The coating is preferably continuous and / or homogenous. The surfaces may be skin, hair, or nails.

[0159] With coating, a covering that is applied to a substrate, in particular to the surface of a substrate, is meant. The coating itself may be an all-over coating, completely covering the substrate, or it may only cover parts of the substrate. Preferably, the coating covers the surface to be treated.

[0160] A thin coating is preferred. For example, a thin coating has a thickness of between 10 nm and 1 mm.

[0161] The coating may be applied via spreading, rinsing, or spraying.

[0162] The substrate may be skin, hair, or mucosa.

[0163] In a fourth aspect, the present invention relates to the use of the cosmetic composition of the first aspect for skin, hair, or nail repair.

[0164] Hair may be thermally or chemically damaged. Hair may be dry, brittle, broken, frizzled, has split ends and no shine or fullness / volume anymore. The cosmetic composition of the present invention specifically repairs and protects hair by smoothing hair, moisturizing hair, dematting the hair structure, strengthening hair fibers, and improving overall texture of hair.

[0165] Skin may be damaged due to sunlight. Damaged skin can look tight, cracked, irritated, rough, inflamed, discoloured, or scarred, depending on the type of damage and its severity.

[0166] The cosmetic composition of the present invention specifically improves skin appearance, e.g. by moisturizing skin or smoothing skin structure.

[0167] In a fifth aspect, the present invention relates to the use of the cosmetic composition of the first aspect for skin, hair, or nail protection.The cosmetic composition of the present invention forms a film / coating onto skin or hair and thereby forms a skin or hair barrier shielding it from high temperatures, sunlight, humidity, salt water, pollution, chemical agents (e.g. colourants) and other environmental stressors. Thereby, the skin or hair looks healthy, shiny and strong. The nails are likewise protected.

[0168] In a sixth aspect, the present invention relates to the use of the cosmetic composition of the first aspect to fix one or more cosmetic ingredients to skin, hair, nails, and / or mucosa.

[0169] The fixation of one or more cosmetic ingredients, for example, prolongs their persistence on skin, hair, or nails.

[0170] As to the different cosmetic ingredients which may be fixed, it is referred to the first aspect of the present invention.

[0171] In a seventh aspect, the present invention relates to a coating / film made from / comprising the cosmetic composition of the first aspect.

[0172] In one embodiment, the coating is a uniform and / or homogenous coating. It has preferably a thickness of between 10 nm and 1 mm and more preferably a thickness of between 50 nm and 0.5 pm.

[0173] The coating may be applied via spreading, rinsing, or spraying.

[0174] The coating may be present on skin, hair, nails, or mucosa.

[0175] Various modifications and variations of the invention will be apparent to those skilled in the art without departing from the scope of invention. Although the invention has been described in connection with specific preferred embodiments, it should be understood that the invention as claimed should not be unduly limited to such specific embodiments. Indeed, various modifications of the described modes for carrying out the invention which are obvious to those skilled in the art in the relevant fields are intended to be covered by the present invention.

[0176] BRIEF DESCRIPTION OF THE FIGURE

[0177] The following figures are merely illustrative of the present invention and should not be construed to limit the scope of the invention as indicated by the appended claims in any way.

[0178] FIGURE 1: Shows the L6 protein solution before (A) and after (B) centrifugation.

[0179] FIGURE 2: Shows the film forming setup with L6 solutions.

[0180] FIGURE 3: Shows the L6 film after incubation of 16 h at room temperature (A) and 37 °C (B).

[0181] FIGURE 4: Shows the L6 film from 75 mg / mL solution after drying.

[0182] FIGURE 5: Shows the B2 film after incubation of 16 h at room temperature (A) and 37 °C (B).

[0183] FIGURE 6: Shows solubilized B2 at a concentration of 400 mg / ml.EXAMPLES

[0184] The examples given below are for illustrative purposes only and do not limit the invention described above in any way.

[0185] 1. Experiment

[0186] Production of beta-solenoid proteins L6 and B2

[0187] The nucleotide sequence encoding L6 and B2 was cloned into an expression plasmid. The expression plasmid was transformed into bacterial cells.

[0188] 1 L of 2xYT medium was inoculated with 5 ml LB overnight cultures for both proteins (all media with appropriate antibiotics). The 1 L cultures were grown at 37°C until reaching an ODeoo of 1. Protein expression was then induced with 0.1 % filter sterilized rhamnose and the cultures grown overnight at 21°C. Cells were harvested and resuspended in lysis buffer (100 mM bicine and 150 mM NaCl buffer titrated to pH 9.0 with NaOH). The cells were sonicated and clarified by centrifugation at 40,000 x g for 40 min. The proteins were purified with a nickel-nitrilotriacetic acid (Ni-NTA) column; washed with 100 mM bicine, 150mM NaCl, and 50 mM imidazole at pH 9.0; and eluted in 100 mM bicine, 150 mM NaCl, and 500 mM imidazole at pH 9.0. The new proteins were found to be well expressed.

[0189] Water solubility test

[0190] Beta-solenoid proteins are of interest for cosmetic applications. Therefore, an initial test was made to analyze the water solubility of these proteins. The test was exemplarily performed for the betasolenoid proteins L6 and B2.

[0191] In the following, the water solubility test for L6 is described.

[0192] • 75 mg / mL L6 solution was prepared in distilled water

[0193]

[0194] solution turbid with visible precipitate (see FIGURE 1A)

[0195] o centrifugation was carried out at 17000 g for 5 min

[0196]

[0197] clear solution with the pellet at the bottom (see FIGURE IB)

[0198] o measured concentration with Nanodrop 57 mg / mL

[0199] 80 mg / mL solutions prepared in 500 mM HEPES pH 7.5 and 4x PBS pH 7.5 same concentration measurementIt was shown that the beta-solenoid protein L6 is soluble in water and aqueous buffer systems. In additional experiments, a water solubility of about 400 mg / ml could be achieved. The betasolenoid protein B2 was tested for water solubility in the same way. Like L6, B2 is soluble in water, e.g. up to 400 mg / ml (see FIGURE 6).

[0200] Film-forming test

[0201] An additional test was made to analyze the film-forming properties of beta-solenoid proteins. The test was exemplarily performed for the beta-solenoid proteins L6 and B2.

[0202] Experimental setup to test the film-forming properties of L6:

[0203] • 200 pL of L6 protein solution in water spread on a specified material (2 technical replicates) (see FIGURE 2) and left to dry overnight

[0204] • Materials

[0205] o glass slides for microscopy

[0206] o black plastic boats for weighing chemicals

[0207] • Protein concentration (w / v)

[0208] o 75 mg / mL

[0209] o 37.5 mg / mL

[0210] o 18.7 mg / mL

[0211] • Temperature

[0212] o room temperature

[0213] O 37°C

[0214] It was shown that a L6 protein film formed at all protein concentrations. The film firmly attached to glass. It was pliable and not brittle even when dried at 37°C. Other protein films (e.g. silk protein films) can be brittle without additives like glycerine. FIGURE 3A shows the result of the L6 protein film drying at room temperature and FIGURE 3B shows the result of the L6 protein film drying at 37°C. Another example of a L6 protein film is shown in FIGURE 4.

[0215] The beta-solenoid protein B2 was tested for film-forming properties in the same way. Like L6, B2 formed films at all protein concentrations (FIGURE 5 A and B). The films were very thin, on skin, these films are almost invisible.SEQUENCE SUMMARY

[0216] SEQ ID NO: 1 (Module A) ARTTGARLDDADLRGATVDPVLWRTASLRGAKMEEEQRREYERARG

[0217] SEQ ID NO: 2 (Module B)

[0218] GGQGGQGGSGGSAAAAAAAAGGSGGSGGQGGQ

[0219] SEQ ID NO: 3 (Module C)

[0220] RMRRDEILEEYRRGRRNFQHINLQEIELTN

[0221] SEQ ID NO: 4 (consensus sequence)

[0222] A (N / D) L * X (SEQ ID NO: 4), wherein * is a polar amino acid residue, preferably selected from the group consisting of C, R, H, K, D, E, S, T, N, and Q, and X is any amino acid residue.

[0223] SEQ ID NO: 5 (B module + C module) GGQGGQGGSGGSAAAAAAAAGGSGGSGGQGGQRMRRDEILEEYRRGRRNFQHINLQE IELTN

[0224] SEQ ID NO: 6 (A module + B module + C module) ARTTGARLDDADLRGATVDPVLWRTASLRGAKMEEEQRREYERARGGGQGGQGGSG GSAAAAAAAAGGSGGSGGQGGQRMRRDEILEEYRRGRRNFQHINLQEIELTN

[0225] SEQ ID NO: 7 (A module + B module) ARTTGARLDDADLRGATVDPVLWRTASLRGAKMEEEQRREYERARGGGQGGQGGSG GSAAAAAAAAGGSGGSGGQGGQ

[0226] SEQ ID NO: 8 ASLTGADLSYANLHHANLSRANLRSADLRNANLSHANLSGANLEEANLEAANLRGADL HEANLSGADLQEANLTQANLKDANLSDANLEQADLAGADLQGAVLDGANLHGANLN NANLSEAMLTRANLEQADLSG

[0227] SEQ ID NO: 9ANLSEASLDGADLEGAMLQDANLSYANLQGADLSEADLEDANLSGANLKNANLSGAN LTGANLHSANLNAANLSQANLRQAVLAGANLTEANLEEANLHRADLHGANLRGADLS GANLEQADLSNANLRRADLTH

[0228] SEQ IDNO: 10 (L6) GGQGGQGGSGGSAAAAAAAAGGSGGSGGQGGQRMRRDEILEEYRRGRRNFQHINLQE IELTNASLTGADLSYANLHHANLSRANLRSADLRNANLSHANLSGANLEEANLEAANL RGADLHEANLSGADLQEANLTQANLKDANLSDANLEQADLAGADLQGAVLDGANLH GANLNNANLSEAMLTRANLEQADLSGARTTGARLDDADLRGATVDPVLWRTASLRGA KMEEEQRREYERARGGGQGGQGGSGGSAAAAAAAAGGSGGSGGQGGQRMRRDEILE EYRRGRRNFQHINLQEIELTNASLTGADLSYANLHHANLSRANLRSADLRNANLSHANL SGANLEEANLEAANLRGADLHEANLSGADLQEANLTQANLKDANLSDANLEQADLAG ADLQGAVLDGANLHGANLNNANLSEAMLTRANLEQADLSGARTTGARLDDADLRGA TVDPVLWRTASLRGAKMEEEQRREYERARGGGQGGQGGSGGSAAAAAAAAGGSGGS GGQGGQRMRRDEILEEYRRGRRNFQHINLQEIELTNASLTGADLSYANLHHANLSRANL RSADLRNANLSHANLSGANLEEANLEAANLRGADLHEANLSGADLQEANLTQANLKD ANLSDANLEQADLAGADLQGAVLDGANLHGANLNNANLSEAMLTRANLEQADLSGA RTTGARLDDADLRGATVDPVLWRTASLRGAKMEEEQRREYERARGGGQGGQGGSGGS AAAAAAAAGGSGGSGGQGGQRMRRDEILEEYRRGRRNFQHINLQEIELTNASLTGADL SYANLHHANLSRANLRSADLRNANLSHANLSGANLEEANLEAANLRGADLHEANLSG ADLQEANLTQANLKDANLSDANLEQADLAGADLQGAVLDGANLHGANLNNANLSEA MLTRANLEQADLSGARTTGARLDDADLRGATVDPVLWRTASLRGAKMEEEQRREYER ARGGGQGGQGGSGGSAAAAAAAAGGSGGSGGQGGQQSDDG

[0229] SEQ ID NO 11 (B2) GGQGGQGGSGGSAAAAAAAAGGSGGSGGQGGQRMRRDEILEEYRRGRRNFQHINLQE IELTNANLSEASLDGADLEGAMLQDANLSYANLQGADLSEADLEDANLSGANLKNANL SGANLTGANLHSANLNAANLSQANLRQAVLAGANLTEANLEEANLHRADLHGANLRG ADLSGANLEQADLSNANLRRADLTHARTTGARLDDADLRGATVDPVLWRTASLRGAK MEEEQRREYERARGGGQGGQGGSGGSAAAAAAAAGGSGGSGGQGGQRMRRDEILEE YRRGRRNFQHINLQEIELTNANLSEASLDGADLEGAMLQDANLSYANLQGADLSEADL EDANLSGANLKNANLSGANLTGANLHSANLNAANLSQANLRQAVLAGANLTEANLEE ANLHRADLHGANLRGADLSGANLEQADLSNANLRRADLTHARTTGARLDDADLRGAT VDPVLWRTASLRGAKMEEEQRREYERARGGGQGGQGGSGGSAAAAAAAAGGSGGSG GQGGQRMRRDEILEEYRRGRRNFQHINLQEIELTNANLSEASLDGADLEGAMLQDANLSYANLQGADLSEADLEDANLSGANLKNANLSGANLTGANLHSANLNAANLSQANLRQA VLAGANLTEANLEEANLHRADLHGANLRGADLSGANLEQADLSNANLRRADLTHART TGARLDDADLRGATVDPVLWRTASLRGAKMEEEQRREYERARGGGQGGQGGSGGSA AAAAAAAGGSGGSGGQGGQRMRRDEILEEYRRGRRNFQHINLQEIELTNANLSEASLD GADLEGAMLQDANLSYANLQGADLSEADLEDANLSGANLKNANLSGANLTGANLHSA NLNAANLSQANLRQAVLAGANLTEANLEEANLHRADLHGANLRGADLSGANLEQADL SNANLRRADLTHARTTGARLDDADLRGATVDPVLWRTASLRGAKMEEEQRREYERAR GGGQGGQGGSGGSAAAAAAAAGGSGGSGGQGGQKSDDG

Claims

CLAIMS1. Cosmetic composition comprising a film-forming, water-soluble structural protein.

2. The cosmetic composition of claim 1, wherein the structural protein has a size of at least 20 kDa, preferably of at least 80 kDa.

3. The cosmetic composition of claim 2, wherein the structural protein has a size of between 20 and 200 kDa, preferably of between 80 and 200 kDa.

4. The cosmetic composition of any one of claims 1 to 3, wherein the structural protein has a water solubility of more than 1 g / 1 (kg / m3), preferably of more than 20 g / 1 (kg / m3), more preferably of more than 40 g / 1 (kg / m3), and even more preferably of more than 100 g / 1 (kg / m3).

5. The cosmetic composition of claim 4, wherein the structural protein has a water solubility of between 10 and 400 g / 1 (kg / m3), preferably of between 30 and 400 g / 1 (kg / m3), more preferably of between 50 and 400 g / 1 (kg / m3), and even more preferably of between 150 and 400 g / 1 (kg / m3).

6. The cosmetic composition of any one of claims 1 to 5, wherein the structural protein is capable of forming a thin continuous film / coating on surfaces without penetrating them.

7. The cosmetic composition of claim 6, wherein the surfaces are selected from the group consisting of skin, hair, and mucosa.

8. The cosmetic composition of any one of claims 1 to 7, wherein the composition is in powder, liquid, or gel form.

9. The cosmetic composition of any one of claims 1 to 8, wherein the concentration of the structural protein in the composition is in the range of between 0.01 wt% / vol and 50 wt% / vol, preferably in the range of between 0.01 wt% / vol and 30 wt% / vol, more preferably in the range of between 0.01 wt% / vol and 20 wt% / vol, and even more preferably in the range of between 0.01 wt% / vol and 2 wt% / vol.

10. The cosmetic composition of any one of claims 1 to 9, wherein the structural protein comprises(a) at least one repeat unit, preferably two, three, or four repeat units, comprising at least one of the following modules: module A having an amino acid sequence according to SEQ ID NO: 1, module B having an amino acid sequence according to SEQ ID NO: 2, and module C having an amino acid sequence according to SEQ ID NO: 3, and / or(b) at least one repeat domain comprising at least five repeats of the following motif:A (N / D) L * X (SEQ ID NO: 4), wherein * is a polar amino acid residue, preferably selected from the group consisting of C, R, H, K, D, E, S, T, N, and Q, and X is any amino acid residue.

11. The cosmetic composition of claim 10, wherein the repeat unit(s) comprise the modules (i) A and B, (ii) B and C, (iii) A and C, or (iv) A, B, and C in any order.

12. The cosmetic composition of claims 10 or 11, wherein the repeat unit(s) is (are independently) selected from the group consisting of SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, a fragment thereof, and a sequence having at least 80% sequence identity thereto.

13. The cosmetic composition of any one of claims 10 to 12, wherein the repeat domain(s) are independently selected from the group consisting of SEQ ID NO: 8, SEQ ID NO: 9, a fragment thereof, and a sequence having at least 80% sequence identity thereto.

14. The cosmetic composition of any one of clams 1 to 13, wherein the structural protein has an amino acid sequence according to SEQ ID NO: 10 (L6) or SEQ ID NO: 11 (B2).

15. The cosmetic composition of any one of clams 1 to 14, wherein the composition further comprises one or more cosmetic ingredients.

16. The cosmetic composition of claim 15, wherein the one or more cosmetic ingredients are selected from the group consisting of actives, functionals, pigments, dyes, fragrances, enzymes, coenzyme, vitamins, hyaluronic acid, peptides, amino acids, ceramides, probiotics, UV protective agents, and antioxidants.

17. The cosmetic composition of any one of clams 1 to 16, wherein the composition further comprises one or more cosmetic carriers.

18. The cosmetic composition of claim 17, wherein the one or more cosmetic carriers are selected from the group consisting of water, liposomes, gels, and polymers.

19. Use of the cosmetic composition of any one of claims 1 to 18 in personal care.

20. The use of claim 19, wherein the personal care is skin care, hair care, nail care, or colour cosmetics.

21. Use of the cosmetic composition of any one of claims 1 to 18 for skin, hair, or nail coating.

22. Use of the cosmetic composition of any one of claims 1 to 18 for skin, hair, or nail repair.

23. Use of the cosmetic composition of any one of claims 1 to 18 for skin, hair, or nail protection.

24. Use of the cosmetic composition of any one of claims 1 to 18 to fix one or more cosmetic ingredients to skin, hair, nails and / or mucosa.

25. Coating / film made from / comprising the cosmetic composition of any one of claims 1 to 18.